Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “COPPER”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 55 records · Page 3Linked to original sources

Trace metal requirements in total parenteral nutrition (TPN). 5. Formation constants for the copper(II)--histidine ternary complexes with threonine, lysine, glycine, phenylalanine, valine, and cystine, and discussion of their implications regarding the copper distribution in blood plasma during TPN and the evaluation of the daily dose of copper.

Specific metal deficiencies have been reported to affect patients receiving total parenteral nutrition (TPN). Our previous studies on the topic were devoted to the computer-based interpretation of the extra urinary excretion of zinc; a theoretical approach was also proposed, with a view to compensating for the extra losses of this metal. Similarly, the present work deals with the problem of TPN-induced copper deficiency and its remedy. As is the case for zinc, the TPN-induced excretion of copper clearly stems from the relative mobilization of the plasma protein-bound pool of this metal into its diffusable low-molecular-weight fraction; this phenomenon being due to the competitive complexation of copper by the amino acids of the nutritive solution. The computer simulation of this effect thus required that first the equilibrium constants be experimentally determined for the main complexes of copper that might form in the solution as well as in plasma during the infusion. Accordingly, complex formation in the copper-histidine ternary systems with threonine, lysine, glycine, phenylalanine, valine, and cystine was investigated by potentiometry at 37 degrees C in NaCIO4 0.15 mol X dm-3. The implications of the results obtained are discussed with regard to the interpretation of the copper excretion and the estimation of the desirable daily dose of this metal for the TPN mixture under consideration.

Amino Acids↗

Chronic exposure of coho salmon to sublethal concentrations of copper.--I. Effect on growth, on accumulation and distribution of copper, and on copper tolerance.

1. Coho salmon, exposed to sublethal levels of aqueous copper (1/4 and 1/2 LC50), lost appetite and ceased growing or showed decreased rates of growth. 2. Recovery of appetite and growth rate was faster in fish exposed to 1/4 of the LC50 than in those exposed to 1/2 of the LC50. 3. Copper levels were elevated in liver gill and kidney of exposed fish with the liver tissue accumulating a much larger amount of the metal than any other tissue. 4. The concentration of liver copper became constant at about the time that growth rate recovered. 5. The exposed fish exhibited much higher resistance to elevated aqueous copper levels than did the controls. 6. The results suggest that coho salmon may become acclimated to higher levels of copper and that acclimated fish are more tolerant to copper than control animals.

Animals↗

CopC protein from Pseudomonas syringae: intermolecular transfer of copper from both the copper(I) and copper(II) sites.

The CopC protein from Pseudomonas syringae pathovar tomato is expressed as one of four proteins encoded by the operon CopABCD that is responsible for copper resistance. It is a small soluble molecule (10.5 kDa) with a beta-barrel structure and features two distinct copper binding sites, which are highly specific for Cu(I) (K(D) > or = 10(-)(13)) and Cu(II) (K(D) approximately 10(-)(15)). These dissociation constants were estimated via ligand competition experiments monitored by electronic spectral and fluorescence probes. The chemistries of the two copper sites are interdependent. When the Cu(II) site is empty, the Cu(I) ion is oxidized by air, but when both sites are occupied, the molecule is stable in air. The availability of an unoccupied site of higher affinity induces intermolecular transfer of either Cu(I) or Cu(II) while maintaining free copper ion concentrations in solution at sub-picomolar levels. This intriguing copper chemistry is consistent with the proposed role of CopC as a copper carrier in the oxidizing periplasmic space. These properties would allow it to exchange either Cu(I) or Cu(II) with its putative partners CopA, CopB, and CopD, contrasting with the role of the Cu(I) (only) chaperones found in the reducing cytoplasm.

Bacterial Proteins↗

The role of copper and protons in heme-copper oxidases: kinetic study of an engineered heme-copper center in myoglobin.

To probe the role of copper and protons in heme-copper oxidase (HCO), we have performed kinetic studies on an engineered heme-copper center in sperm whale myoglobin (Leu-29 --> HisPhe-43 --> His, called Cu(B)Mb) that closely mimics the heme-copper center in HCO. In the absence of metal ions, the engineered Cu(B) center in Cu(B)Mb decreases the O(2) binding affinity of the heme. However, addition of Ag(I), a redox-inactive mimic of Cu(I), increases the O(2)-binding affinity. More importantly, copper ion in the Cu(B) center is essential for O(2) reduction, as no O(2) reduction can be observed in copper-free, Zn(II), or Ag(I) derivatives of Cu(B)Mb. Instead of producing a ferryl-heme as in HCO, the Cu(B)Mb generates verdoheme because the engineered Cu(B)Mb may lack a hydrogen bonding network that delivers protons to promote the heterolytic OO cleavage necessary for the formation of ferryl-heme. Reaction of oxidized Cu(B)Mb with H(2)O(2), a species equivalent in oxidation state to 2e(-), reduced O(2) but, possessing the extra protons, resulted in ferryl-heme formation, as in HCO. The results showed that the Cu(B) center plays a critical role in O(2) binding and reduction, and that proton delivery during the O(2) reduction is important to avoid heme degradation and to promote the HCO reaction.

Amino Acid Sequence↗

Differential decrease of copper content and of copper binding to superoxide dismutase in liver, heart and brain of copper-deficient rats.

Dietary copper-deficiency in rats produced a organ-specific decrease of copper content. This was paralleled by a decrease of the activity of the copper-enzyme superoxide dismutase. In liver such a decrease is partially due to the existence of an apo-form of superoxide dismutase, which can be reactivated by addition of exogenous copper to tissue extracts. These results demonstrate in vivo that superoxide dismutase is post-translationally modulated by copper in higher vertebrates as previously found for yeast and mammalian cells in culture.

Animals↗

Copper deficiency secondary to a copper transport defect: a new copper metabolic disturbance.

We describe a 21-year-old man who developed copper deficiency manifested as a demyelinating neuropathy, chronic intestinal pseudo-obstruction, osteoporosis, testicular failure, retinal degeneration, and cardiomyopathy with a tortuous aorta. His serum copper was low and did not increase despite administration of large doses of intravenous copper sulfate. The ceruloplasmin level as measured by an antibody technique was normal, yet ceruloplasmin (Cp) oxidase activity was very low. The Cp amino acid sequence was normal. This suggests that the copper deficiency was caused by a defect in hepatic processing of copper for incorporation into Cp.

Adult↗

Novel copper(II)-dien-imidazole/imidazolate-bridged copper(II) complexes. Crystal structure of [Cu(dien)(Him)](ClO4)2 and of [(dien)Cu(mu-im)Cu(dien)](ClO4)3, a homobinuclear model for the copper(II) site of the CuZn-superoxide dismutase.

The imidazolate-bridged binuclear copper(II)-copper(II) complex [(dien)Cu(mu-im)Cu(dien)](ClO(4))(3) and related mononuclear complexes [Cu(dien)(H(2)O)](ClO(4))(2), [Cu(dien)(Him)](ClO(4))(2) were synthesized with diethylenetriamine (dien) as capping ligand. The crystal structure of mononuclear [Cu(dien)(Him)](ClO(4))(2) and binuclear complex [(dien)Cu(mu-im)Cu(dien)](ClO(4))(3) have been determined by single crystal X-ray diffraction methods. The mononuclear complex [Cu(dien)(Him)](ClO(4))(2) crystallizes in the orthorhombic, Pca2(1) with a = 9.3420(9) A, b = 12.3750(9) A, c = 14.0830(9) A, beta = 90.000(7)(o) and Z = 4 and binuclear complex [(dien)Cu(mu-im)Cu(dien)](ClO(4))(3) crystallizes in the monoclinic space group P2(1)/a, with a = 15.017(7) A, b = 11.938(6) A, c = 15.386(6) A, beta = 110.30(4)(o) and Z = 4. The molecular structures show that copper(II) ions in an asymmetrically elongated octahedral coordination (type 4 + 1 + 1) and in binuclear complex Cu(1) atom has a asymmetrically elongated octahedral coordination (type type 4 + 1 + 1) and Cu(2) atom exhibits a square base pyramidal coordination (type 4 + 1). The bridging ligand (imidazolate ion, im) lies nearly on a straight line between two Cu(2+), which are separated by 5.812 A, slightly shorter than the value in copper-copper superoxide dismutase (Cu(2)-Cu(2)SOD). Magnetic measurements and electron spin resonance (ESR) spectroscopy of the binuclear complex have shown an antiferromagnetic exchange interaction. From pH-dependent cyclic voltametry (CV) and electronic spectroscopic studies the complex has been found to be stable over a wide pH range (7.75-12.50).

Absorption↗

Architecture dependence on the steric constrains of the ligand in cyano-bridged copper(I) and copper(II)-copper(I) mixed-valence polymer compounds containing diamines: crystal structures and spectroscopic and magnetic properties.

A family of cyano-bridged copper(II)-copper(I) mixed-valence polymers containing diamine ligands of formula [Cu(pn)(2)][Cu(2)(CN)(4)] (1, pn = 1,2-propanediamine), [Cu(2)(CN)(3)(dmen)] (2, dmen = N,N-dimethylethylenediamine), and [Cu(3)(CN)(4)(tmen)] (3, tmen = N,N,N',N'-tetramethylethylenediamine) have been prepared with the aim of analyzing how their architecture may be affected by steric constraints imposed by the diamine ligands. In the absence of diamine and with use of the voluminous NEt(4)(+) cation, the copper(I) polymer [NEt(4)][Cu(2)(CN)(3)] (4) forms. The structure of 1 consists of a three-dimensional diamond-related anionic framework host, [Cu(2)(CN)(4)](2-), and enclathrated [Cu(pn)(2)](2+) cations. The structure of 2 is made of neutral corrugated sheets constructed from fused 18-member nonplanar rings, which contain three equivalent copper(I) and three equivalent copper(II) centers bridged by cyanide groups in an alternative form. The 3D structure of 3 consists of interconnected stair-like double chains built from fused 18-member rings, which adopt a chairlike conformation. Each ring is constructed from two distorted trigonal planar Cu(I) centers, two bent seemingly two-coordinated Cu(I) centers, and two pentacoordinated Cu(II) atoms. The structure 4 is made of planar anionic layers [Cu(2)(CN)(3)](n)(n-) lying on mirror planes and NEt(4)(+) cations intercalated between the anionic layers. From the X-ray structural results and calculations based upon DFT theory some conclusions are drawn on the structure-steric factors correlation in these compounds. Compound 1 exhibits very weak luminescence at 77 K with a maximum in the emission spectrum at 520 nm, whereas compound 4 shows an intense luminescence at room temperature with a maximum in the emission spectrum at 371 nm. Polymers 2 and 3 exhibit weak antiferromagnetic magnetic exchange interactions with J = -0.065(3) and -2.739(5) cm(-1), respectively. This behavior have been justified on the basis of the sum of two contributions: one arising from the pure ground-state configuration and the other one from the charge-transfer configuration Cu(I)-CN-Cu(II)-CN-Cu(II) that mixes with the ground-state configuration.

Journal Article↗

New Type 2 Copper-Cysteinate Proteins. Copper Site Histidine-to-Cysteine Mutants of Yeast Copper-Zinc Superoxide Dismutase.

Preparation and characterization of two new site-directed mutant copper-zinc superoxide dismutase proteins from Saccharomyces cerevisiae, i.e., His46Cys (H46C) and His120Cys (H120C), in which individual histidyl ligands in the copper-binding site were replaced by cysteine, are reported here. These two mutant CuZnSOD proteins may be described as type 2 (or normal) rather than type 1 (or blue) copper-cysteinate proteins and are characterized by their yellow rather than blue color, resulting from intense copper-to-sulfur charge transfer bands around 400 nm, their type 2 EPR spectra, with large rather than small nuclear hyperfine interactions, and their characteristic type 2 d-d electronic absorption spectra. An interesting difference between these two copper site His-to-Cys mutations is that the imidazolate bridge between the two metal sites that is characteristic of the wild-type protein remains intact in the case of the H46C mutant but is not present in the case of the H120C mutant.

Journal Article↗

The effect of copper-amended fertiliser and copper oxide wire particles on the copper status of farmed red deer (Cervus elaphus) and their progeny.

AIM: To determine changes in serum and liver copper concentrations in postnatal, weaner, yearling, and mature deer after grazing pasture topdressed with copper (Cu) at two rates of application of copper sulphate (CuSO4(.)5H2O), and following oral administration of copper oxide (CuO) wire particles to some of the deer. METHODS: In mid-March 2000 (Year 1), 1.1-ha paddocks (two/treatment) of ryegrass/white clover pasture received either 0 (Control), 6 (Low) or 12 (High) kg CuSO4(.)5H2O /ha applied with 250 kg potash superphosphate/ha. They were grazed by 4-month-old red deer hinds (n=11/treatment) from mid-April 2000 until early March 2001. In mid-March 2001 (Year 2), the pastures were topdressed again as for Year 1, and the original hinds, now yearlings which had grazed as a single group between studies, were returned to their respective treatments in mid-April 2001 and remained on the trial until mid-March 2002. They were mated during April/May. The pastures were also grazed by pregnant mature hinds (n=8/treatment) from mid-May 2001. As the Cu status (i.e. liver Cu concentration) of the yearling hinds on the pasture treated with 6 kg CuSO4(.)5H2O/ha was not significantly different from the untreated animals, in late July 2001 the yearling and mature deer on this treatment were treated orally with 10 g CuO wire particles. The mature hinds calved in November and the yearling hinds in December. Pasture samples were collected at about monthly intervals to determine concentrations of Cu and other minerals. In Year 1, liver biopsies and blood samples were collected at 4-6-weekly intervals for determination of Cu concentrations. In Year 2, samples were collected similarly at 6-12-weekly intervals. Liver biopsies and blood were also collected from progeny, along with milk from their dams. Liveweights were determined at 3-7-monthly intervals, as well as data on calving/mortality rates. RESULTS: Pasture Cu concentrations before the application of CuSO4(.)5H2O were 6-9 mg Cu/kg dry matter (DM) and remained at this level in the untreated Control paddocks throughout the study. In Year 1, 28 days after treatment, pasture Cu concentration was 25 and 35 mg Cu/kg DM for the Low and High treatments, respectively; while at the same time for the same treatments in Year 2 it was 20 and 60 mg/kg DM, respectively. A second 60 mg Cu/kg DM peak also occurred on Day 85 in Year 2 with the High treatment. The pasture Cu concentration returned to 6-9 mg/kg DM, and there were no differences between treatments at Days 80 and 150 in Years 1 and 2, respectively. In Years 1 and 2, the Low treatment had no significant effect on the Cu status of the weaner and yearling hinds, respectively, when compared with that of animals grazing the untreated Control pastures. Weaner (Year 1) and yearling (Year 2) deer on the High treatment had significantly higher mean serum and liver Cu concentrations in the late winter and spring period when compared with those on untreated Control pastures. CuO wire particles increased the mean serum Cu concentration at Days 60 and 180, and liver Cu concentration at Day 60, in yearling hinds. A similar effect was observed in mature hinds. Regardless of Cu treatment, the liver Cu concentration of the 1-4-week-old progeny was markedly greater (p<0.001) than that of their dams, and then decreased significantly until weaning in March. In progeny of treated yearling hinds, but not mature hinds, serum and liver Cu concentrations were significantly higher (p=0.013) than progeny of untreated dams. CONCLUSION: Topdressing pastures with CuSO4(.)5H2O at a rate of 12 kg/ha, but not 6 kg/ha, in mid-March was effective in increasing the Cu status of weanling hinds; while pastures topdressed with 12 kg CuSO4(.)5H2O /ha in mid-March and dosing hinds with 10 g CuO in late July were effective in increasing the Cu status of pregnant hinds, and in the case of the yearling hinds, significantly improved the Cu status of their progeny from birth to weaning.

Animal Feed↗

Paramagnetic resonance in imidazolate-bridged homobinuclear (copper-copper) and heterobinuclear (copper-zinc) complexes.

Bridged homobinuclear (copper-copper) and heterobinuclear (copper-zinc) complexes of diethylenetriamine have been prepared with 2-methyl-imidazole as bridging ligand. EPR spectra of the polycrystalline complexes have been studied at room temperature and also at liquid nitrogen temperature. Low temperature EPR and electronic spectroscopic studies of 50% aqueous DMSO of [(dien)Cu-(Melm)-Zn(dien)]3+ solutions show the imidazolate bridged complex to exist mainly over the pH range approximately 7.0 < pH < 10.0. At low pH the 2-MelmH+ ion and mononuclear copper and zinc complexes are formed. Above pH > 10.0 hydroxide ion splits the imidazolate bridge.

Copper↗

Trigonal planar copper(I) complex: synthesis, structure, and spectra of a redox pair of novel copper(II/I) complexes of tridentate bis(benzimidazol-2'-yl) ligand framework as models for electron-transfer copper proteins.

The copper(II) and copper(I) complexes of the chelating ligands 2,6-bis(benzimidazol-2'-ylthiomethyl)pyridine (bbtmp) and N,N-bis(benzimidazol-2'-ylthioethyl)methylamine (bbtma) have been isolated and characterized by electronic and EPR spectra. The molecular structures of a redox pair of Cu(II/I) complexes, viz., [Cu(bbtmp)(NO(3))]NO(3), 1, and [Cu(bbtmp)]NO(3), 2, and of [Cu(bbtmp)Cl], 3, have been determined by single-crystal X-ray crystallography. The cation of the green complex [Cu(bbtmp)(NO(3))]NO(3) possesses an almost perfectly square planar coordination geometry in which the corners are occupied by the pyridine and two benzimidazole nitrogen atoms of the bbtmp ligand and an oxygen atom of the nitrate ion. The light-yellow complex [Cu(bbtmp)]NO(3) contains copper(I) with trigonal planar coordination geometry constituted by the pyridine and two benzimidazole nitrogen atoms of the bbtmp ligand. In the yellow chloride complex [Cu(bbtmp)Cl] the asymmetric unit consists of two complex molecules that are crystallographically independent. The coordination geometry of copper(I) in these molecules, in contrast to the nitrate, is tetrahedral, with pyridine and two benzimidazole nitrogen atoms of bbtmp ligand and the chloride ion occupying the apexes. The above coordination structures are unusual in that the thioether sulfurs are not engaged in coordination and the presence of two seven-membered chelate rings facilitates strong coordination of the benzimidazole nitrogens and discourage any distortion in Cu(II) coordination geometry. The solid-state coordination geometries are retained even in solution, as revealed by electronic, EPR, and (1)H NMR spectra. The electrochemical behavior of the present and other similar CuN(3) complexes has been examined, and the thermodynamic aspects of the electrode process are correlated to the stereochemical reorganizations accompanying the redox changes. The influence of coordinated pyridine and amine nitrogen atoms on the spectral and electrochemical properties has been discussed.

Benzimidazoles↗

Release of copper from yeast copper-thionein after S-alkylation of copper-thiolate clusters.

Our knowledge on the release of copper from Cu-thionein in biological systems is limited. Other than oxidative cleavage or direct transfer, the possibility of an alkylation mechanism seemed attractive. Iodoacetamide and methyl methanesulphonate were successfully employed to alkylate the Cu-thiolate sulphur atom of homogeneous Cu(I)-thionein from yeast. The alkylation caused a weakening of the Cu-S bonding, which led to the release of copper. After equilibrium dialysis a proportion of the released copper was found in the dialysis buffer. When iodoacetamide was used carboxymethylcysteine was detected in the protein hydrolysate. A 10-fold molar excess over cysteine was sufficient for complete alkylation, which could be conveniently monitored by c.d. at 328 and 359 nm. The reaction proceeded under both aerobic and anaerobic conditions. E.p.r. measurements of Cu2+ revealed unequivocally the complete cleavage of the Cu-thiolate bonding in less than 5 h. It is possible that this mode of copper release might be of relevance to the molecular transport of this biochemically important transition metal.

Alkylation↗

Dithionite reduction kinetics of the dissimilatory copper-containing nitrite reductase of Alcalegenes xylosoxidans. The SO(2)(.-) radical binds to the substrate binding type 2 copper site before the type 2 copper is reduced.

We report here the first detailed study of the dithionite reduction kinetics of a copper-containing dissimilatory nitrite reductase (NiR). The reduction of the blue type 1 copper (T1Cu) center of NiR preparations that contained both type 1 and type 2 copper atoms, followed biphasic kinetics. In contrast, NiR that was deficient in type 2 copper (T2DNiR), followed monophasic kinetics with a second-order rate constant (T2D)k = 3.06 x 10(6) m(-1) s(-1). In all cases the SO(2)(.-) radical rather than S(2)O(4)(2-) was the effective reductant. The observed kinetics were compatible with a reaction mechanism in which the T1Cu of the fully loaded protein is reduced both directly by dithionite and indirectly by the type 2 Cu (T2Cu) site via intramolecular electron transfer. Reduction kinetics of the T2Cu were consistent with SO(2)(.-) binding first to the T2Cu center and then transferring electrons (112 s(-1)) to reduce it. As SO(2)(.-) is a homologue of NO(2)(-), the NiR substrate, it is not unlikely that it binds to the catalytic T2Cu site. Effects on the catalytic activity of the enzyme using dithionite as a reducing agent are discussed. Reduction of the semireduced T1Cu(I)T2Cu(II) state followed either second-order kinetics with k(2) = 3.33 x 10(7) m(-1) s(-1) or first-order kinetics with 52.6 s(-1) < (T1red)k(1) < 112 s(-1). Values of formation constants of the T1Cu(II)T2Cu(II)-SO(2)(.-) and T1Cu(I)T2Cu(II)-SO(2)(.-) adducts showed that the redox state of T1Cu affected binding of SO(2)(.-) at the catalytic T2Cu center. Analysis of the kinetics required the development of a mathematical protocol that could be applied to a system with two intercommunicating sites but only one of which can be monitored. This novel protocol, reported for the first time, is of general application.

Alcaligenes↗

Copper administration to young calves: oral dosing with copper oxide compared with subcutaneous copper glycinate injection.

Calves were dosed with 50 g of copper oxide granules orally or given 120 mg copper glycinate subcutaneously. There was no significant difference between the weights of calves given either treatment during the trial. However, the copper oxide treatment resulted in sustained higher concentration of plasma copper and higher liver reserves than the glycinate treatment.

Administration, Oral↗

Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine system.

OBJECTIVE: This study was conducted to evaluate the effect of a miniaturized frameless copper IUD (GyneFix 200 small) and a copper-levonorgestrel (GynePlant) intrauterine system (IUS) on the amount of menstrual blood loss (MBL). METHODS: In 60 Belgian women using GyneFix 200 and 21 using GynePlant, MBL was assessed with the visual assessment technique. RESULTS: MBL scores in GyneFix 200 users did not change from baseline during the mean observation period of 31 months. In GynePlant users, mean MBL scores decreased by at least 50% in all but one user. CONCLUSION: The impact of copper IUDs on MBL can be minimized by reducing the surface area of the foreign body. Reduction of MBL, without causing amenorrhea, can be obtained by adding levonorgestrel.

Adolescent↗

Understanding copper trafficking in bacteria: interaction between the copper transport protein CopZ and the N-terminal domain of the copper ATPase CopA from Bacillus subtilis.

In this paper the interaction of cytoplasmic CopZ and the N-terminal domain of the CopA ATPase from Bacillus subtilis has been studied by NMR through (15)N-(1)H HSQC experiments in order to understand the role of the two proteins in the whole copper trafficking mechanism of the bacteria. It appears that the two proteins interact in a fashion similar to that of the yeast homologue proteins [Arnesano, F., Banci, L., Bertini, I., Cantini, F., Ciofi-Baffoni, S., Huffman, D. L., and O'Halloran, T. V. (2001) J. Biol. Chem. 276, 41365-41376], although the surface potentials are reversed. A structural model for the interaction is proposed. (15)N mobility studies on the free proteins and on their complex are also reported. From these data, it appears that copper is largely transferred from CopZ to CopA, thus suggesting their possible involvement in a detoxification process. Comparing functional data of homologous proteins of other bacteria, it can be concluded that this class of proteins is involved in copper homeostasis but the specific roles are species dependent.

Adenosine Triphosphatases↗